Cargando…
Effect of Administration of Single Dose GnRH Agonist in Luteal Phase on Outcome of ICSI-ET Cycles in Women with Previous History of IVF/ICSI Failure: A Randomized Controlled Trial
BACKGROUND: GnRH agonist administration in the luteal phase has been suggested to beneficially affect the outcome of intracytoplasmic sperm injection (ICSI) and embryo transfer (ET) cycles. This blind randomized controlled study evaluates the effect of GnRH (Gonadotropine Releasing Hormone) agonist...
Autores principales: | Zafardoust, Simin, Jeddi-Tehrani, Mahmood, Akhondi, Mohammad Mehdi, Sadeghi, Mohammad Reza, Kamali, Koroush, Mokhtar, Sara, Badehnoosh, Bita, Arjmand-Teymouri, Fatemeh, Fatemi, Farnaz, Mohammadzadeh, Afsaneh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Avicenna Research Institute
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386092/ https://www.ncbi.nlm.nih.gov/pubmed/25927026 |
Ejemplares similares
-
ART Outcomes in GnRH Antagonist Protocol (Flexible) and Long GnRH Agonist Protocol during Early Follicular Phase in Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial
por: Mokhtar, Sara, et al.
Publicado: (2015) -
Estradiol pretreatment in GnRH antagonist protocol for IVF/ICSI treatment
por: Zhu, Shaomi, et al.
Publicado: (2022) -
Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis
por: Oliveira, João Batista A, et al.
Publicado: (2010) -
GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article
por: Alyasin, Ashraf, et al.
Publicado: (2016) -
Is the GnRH Antagonist Protocol Effective at Preventing OHSS for Potentially High Responders Undergoing IVF/ICSI?
por: Xing, Weijie, et al.
Publicado: (2015)